PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis extracts. Ubiquo is a knowledge management and medical consultation system that aims to create access to healthcare for Colombians.
Follow-Up Questions
Who is the CEO of Pharmacielo Ltd?
Mr. Marc Lustig is the Chairman of the Board of Pharmacielo Ltd, joining the firm since 2020.
What is the price performance of PCLOF stock?
The current price of PCLOF is $0.024, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Pharmacielo Ltd?
Pharmacielo Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Pharmacielo Ltd market cap?
Pharmacielo Ltd's current market cap is $4.5M
Is Pharmacielo Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Pharmacielo Ltd, including 1 strong buy, 4 buy, 1 hold, 0 sell, and 1 strong sell
